Spero Therapeutics SPRO 深 沪
已收盘 10-30 16:00:00 美东时间
1.06
-0.050
-4.50%
华盛通- 最 高1.115
- 今 开1.11
- 成交量 30.99万股
- 最 低 1.05
- 昨 收 1.11
- 总市值 6172.89万
- 52周最高 3.08
- 市盈率 静 7.30
- 换手率 0.53%
- 52周最低 1.04
- 委 比 42.10%
- 总股本 5823.48万
- 历史最高 23.639
- 量 比 0.82
- 振 幅 5.86%
- 历史最低 0.5052
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅163.5%！BTIG上调Cullinan Therapeutics目标价至41美元，维持"买入"评级
今日重点评级关注：BTIG：维持Cullinan Therapeutics"买入"评级，目标价从40美元升至41美元；Rosenblatt：维持SK海力士"买入"评级，目标价从320美元升至400美元
10-29 12:30
Cantor Fitzgerald Initiates Coverage On Spero Therapeutics with Overweight Rating, Announces Price Target of $6
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Spero Therapeutics (NASDAQ:SPRO) with a Overweight rating and announces Price Target of $6.
10-28 18:35
Spero Therapeutics announces planned COO retirement and transition
Spero Therapeutics ( ($SPRO) ) just unveiled an announcement. On October 26, 20...
10-28 05:50
Spero Therapeutics收跌3.6%，成交额55.19万美元
10月27日，Spero Therapeutics（SPRO）收跌3.6%，报1.07美元，成交额55.19万美元，市值6231.13万美元。 行情数据 • 开...
10-27 07:17
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Spero Therapeutics appoints Amy Rock, Ph.D., as Chief Regulatory and Quality Officer and Dae Gon Ha, Ph.D., as Senior Vice President, Corporate Development. Rock brings over 25 years of experience in regulatory affairs and immunotherapy development, while Ha has expertise in biopharma markets and business development. Additionally, Chief Operating Officer Timothy Keutzer will retire after 11 years, during which he played a key role in advancing U...
10-26 12:00
Spero Therapeutics收跌2.65%，成交额40.82万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:20
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics announced the approval of 233,000 restricted stock units (RSUs) and 323,000 stock options granted to new employees under its 2019 Inducement Plan. These awards, granted on October 1, 2026, vest over time and are intended to incentivize new hires. The stock options vest 25% on the first anniversary of employment, with the remainder vesting monthly over 36 months. RSUs vest in four equal annual installments. The company focuses o...
10-02 20:05
美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多
今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元
09-15 15:30
Meta Platforms To $650? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wedbush raised the price target for Meta Platforms Inc (NASDAQ:META) from $595 to $650. Wedbush analyst Ygal A...
09-14 21:01
HC Wainwright & Co. Maintains Buy on Spero Therapeutics, Raises Price Target to $6
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Spero Therapeutics (NASDAQ:SPRO) with a Buy and raises the price target from $5 to $6.
09-14 18:42
